AOD Thesaurus.  Annotated Hierarchy.  chemical substances by structure.  Z - ZH14.2
b-out  To Broad Outline    d-out  To Detailed Outline     qh  To Quick Hierarchy
Previous Annotated Hierarchy section    Next Annotated Hierarchy section     Search



Zchemical substances by structure   b-out   d-out   qh
SN This section presents one of many possible linear arrangements of the chemical compound hierarchy. There are many hierarchical relationships not shown. The chemical hierarchy is so complex that it requires a chemical substructure search system.
RT BN other specific drug of abuse    qh   ah
+EB8e biosynthesis    qh   ah
+OA technology, manufacturing, and agriculture    qh   ah
+RJ2 chemical substance as study subject    qh   ah
+YCe enzymes    qh   ah


ZAechemical elements   d-out   qh

ZA2elements by periodic group   qh
ZA2.2e.  hydrogen   qh
ZA2.2.2e.  .  deuterium   qh
ZA2.2.4e.  .  tritium   qh
ZA2.4e.  metals   qh
RT+BX2.2.4e congener    qh   ah
ZA2.4.2e.  .  alkali metals   qh
ZA2.4.2.2e.  .  .  lithium   qh
BT+YP4.6e alcohol withdrawal agents    qh   ah
+YP4.8.12.6 agents for alcohol-concurrent depression    qh   ah
+YW4.10e tranquilizers    qh   ah
ZA2.4.2.4e.  .  .  sodium   qh
ST Na
RT+YM4e biological electrolytes    qh   ah
ZA2.4.2.6e.  .  .  potassium   qh
RT+YM4e biological electrolytes    qh   ah
ZA2.4.2.8e.  .  .  rubidium   qh
BT+YA4.2 trace elements    qh   ah
ZA2.4.2.10e.  .  .  cesium   qh
ZA2.4.4e.  .  alkaline earth metals   qh
ZA2.4.4.2e.  .  .  beryllium   qh
ZA2.4.4.4e.  .  .  magnesium   qh
ST Mg
NT+GR12.6e magnesium metabolism disorder    qh   ah
BT+YA4.2 trace elements    qh   ah
RT GT2.6.18 sideroblastic anemia    qh   ah
+YM4e biological electrolytes    qh   ah
ZA2.4.4.6e.  .  .  calcium   qh
ST Ca
NT+EB28.2e calcium metabolism    qh   ah
+GR12.10e calcium metabolism disorder    qh   ah
BT+ZO6.4.10.6.4e blood coagulation factors    qh   ah
RT+EG16.2e mitochondrial transport    qh   ah
+GH14.4.8e mineral deficiency    qh   ah
+YA4e mineral nutrients    qh   ah
 YG26 parathyroid hormone    qh   ah
+YM2.2e second messengers    qh   ah
+YM4e biological electrolytes    qh   ah
ZA2.4.4.8e.  .  .  strontium   qh
ZA2.4.4.10e.  .  .  barium   qh
ZA2.4.4.12e.  .  .  radium   qh
ZA2.6e.  zinc group elements   qh
ZA2.6.2e.  .  zinc   qh
ST Zn
BT+YA4.2 trace elements    qh   ah
RT YC14.38e superoxide dismutases    qh   ah
ZA2.6.4e.  .  cadmium   qh
ZA2.6.6e.  .  mercury   qh
ZA2.8e.  boron group elements   qh
ZA2.8.2e.  .  boron   qh
ZA2.8.4e.  .  aluminum   qh
ZA2.8.6.  .  gallium   qh
ZA2.8.8.  .  indium   qh
ZA2.8.10e.  .  thallium   qh
ST Th
ZA2.10e.  carbon group elements   qh
ZA2.10.2e.  .  carbon   qh
ZA2.10.4e.  .  silicon   qh
BT+YA4.2 trace elements    qh   ah
ZA2.10.6e.  .  germanium   qh
ZA2.10.8e.  .  tin   qh
ST Sn
ZA2.10.10e.  .  lead   qh
ST Pb
RT BX2.2.2e alcohol contaminant    qh   ah
 GT2.6.18 sideroblastic anemia    qh   ah
ZA2.12e.  nitrogen group elements   qh
ZA2.12.2e.  .  nitrogen   qh
ZA2.12.4e.  .  phosphorus   qh
NT EB28.4e phosphorus metabolism    qh   ah
 GR12.8 phosphorus metabolism disorder    qh   ah
ZA2.12.6e.  .  arsenic   qh
ZA2.12.8e.  .  antimony   qh
ZA2.12.10e.  .  bismuth   qh
ZA2.14e.  oxygen group elements   qh
ZA2.14.2e.  .  oxygen   qh
NT CK10.4e oxygen radicals    qh   ah
ZA2.14.4e.  .  sulfur   qh
ZA2.14.6e.  .  selenium   qh
BT+YA4.2 trace elements    qh   ah
ZA2.14.8e.  .  tellurium   qh
ZA2.14.10e.  .  polonium   qh
ZA2.16e.  halogen elements   qh
ZA2.16.2e.  .  fluorine   qh
ZA2.16.4e.  .  chlorine   qh
ST Cl
ZA2.16.6e.  .  bromine   qh
ZA2.16.8e.  .  iodine   qh
ZA2.16.10e.  .  astatine   qh
ZA2.18e.  noble gases   qh
ZA2.18.2e.  .  helium   qh
ZA2.18.4e.  .  neon   qh
ZA2.18.6e.  .  argon   qh
ZA2.18.8e.  .  krypton   qh
ZA2.18.10e.  .  xenon   qh
ZA2.18.12e.  .  radon   qh
ZA2.20e.  transition elements   qh
ZA2.20.2.  .  first transition series   qh
ZA2.20.2.6e.  .  .  chromium   qh
BT+YA4.2 trace elements    qh   ah
ZA2.20.2.8e.  .  .  manganese   qh
ST Mn
BT+YA4.2 trace elements    qh   ah
RT YC14.38e superoxide dismutases    qh   ah
ZA2.20.2.10e.  .  .  iron   qh
ST Fe
NT EB28.6e iron metabolism    qh   ah
+GR12.2e iron metabolism disorder    qh   ah
BT+YA4.2 trace elements    qh   ah
RT GR12.2.4e hemochromatosis    qh   ah
 ZO6.8.2e ferritin    qh   ah
ZA2.20.2.12e.  .  .  cobalt   qh
ST Co
BT+YA4.2 trace elements    qh   ah
RT BX2.2.2e alcohol contaminant    qh   ah
ZA2.20.2.14e.  .  .  nickel   qh
ZA2.20.2.16e.  .  .  copper   qh
ST Cu
NT+GR12.4 copper metabolism disorder    qh   ah
BT+YA4.2 trace elements    qh   ah
RT YC14.38e superoxide dismutases    qh   ah
ZA2.20.4.  .  second transition series   qh
ZA2.20.4.16e.  .  .  silver   qh
ZA2.20.6.  .  third transition series   qh
ZA2.20.6.12e.  .  .  iridium   qh
ZA2.20.6.14e.  .  .  platinum   qh
ZA2.20.6.16e.  .  .  gold   qh
ZA2.22.  rare earth elements   qh
ZA2.24e.  radioactive chemical elements   qh
ZA2.24.2.  .  actinide elements   qh
ZA2.24.2.2e.  .  .  thorium   qh
ZA2.24.2.4e.  .  .  uranium   qh


ZBechemical compounds   d-out   qh
NT+ZCe inorganic compounds    qh   ah
+ZDe organic compounds    qh   ah
+ZWe organometallic compounds    qh   ah
+ZXe coordination compounds    qh   ah
+ZYe polymers    qh   ah


ZB2compounds by chemical function   qh

ZB2.2eacids   qh
NT ZC2.4e hydrochloric acid    qh   ah
 ZC10.2.2e perchloric acid    qh   ah
 ZC10.6.2e periodic acid    qh   ah
+ZC12.2e inorganic nitrogen acid    qh   ah
+ZC14.2e phosphoric acid    qh   ah
 ZC14.4e phosphorous acid    qh   ah
+ZC18e inorganic sulfur compounds    qh   ah
RT+BX2.2.4e congener    qh   ah
+YC16.2 acyltransferases    qh   ah

ZB2.4ebases   qh
ZB2.4.2.  Bronsted base   qh
SN A substance that can combine with the ion H+.
ZB2.4.4.  Lewis base   qh
SN A substance that can combine with other substances by donating the electrons that form the bond between them.

ZB2.6esalts   qh
SN Use *ZC4.6 sodium chloride* qh ah for table salt or dietary salt. Salt as used here is a chemical class.

ZB2.8eanhydrides   qh
SN A chemical compound arising by reaction of two acid groups with loss of water.
RT+ZC16.2e oxides    qh   ah


ZCeinorganic compounds   d-out   qh
BT+ZBe chemical compounds    qh   ah
RT+YA4e mineral nutrients    qh   ah

ZC2einorganic hydrogen compounds   qh
ZC2.2e.  water   qh
ZC2.4e.  hydrochloric acid   qh
BT+XM2.2.4.6e gastric juice    qh   ah
+ZB2.2e acids    qh   ah
RT XB2.8.8.2e gastric acid    qh   ah
ZC2.6e.  hydroxides   qh
ST alkalies
caustic

ZC4einorganic sodium compounds   qh
NT ZC12.8.6.6e sodium nitrite    qh   ah
ZC4.2e.  sodium glutamate   qh
BT+YZ6e food additives    qh   ah
ZC4.4e.  sodium hydroxide   qh
ZC4.6e.  sodium chloride   qh
ST dietary salt
table salt
RT+HS2.2 diet therapy    qh   ah
 ZB2.6e salts    qh   ah
ZC4.8e.  sodium hypochlorite   qh
ZC4.10e.  sodium fluoride   qh
ZC4.12e.  sodium iodide   qh

ZC6einorganic potassium compounds   qh
ZC6.2e.  potassium chloride   qh
ST dietary salt substitute
ZC6.4e.  potassium iodide   qh

ZC8einorganic magnesium compounds   qh
ZC8.2e.  permanganate   qh

ZC10einorganic halogen compounds   qh
ST halides
ZC10.2e.  chlorine compounds   qh
ZC10.2.2e.  .  perchloric acid   qh
BT+ZB2.2e acids    qh   ah
+ZC16.10e peroxide    qh   ah
ZC10.2.4e.  .  chlorides   qh
RT+YM4e biological electrolytes    qh   ah
ZC10.2.4.2e.  .  .  chloride ion   qh
ST Cl
ZC10.2.6e.  .  hypochlorite   qh
ST ClO
ZC10.4e.  inorganic fluorine compounds   qh
ZC10.4.2e.  .  fluoride   qh
ZC10.6e.  iodine compounds   qh
ZC10.6.2e.  .  periodic acid   qh
BT+ZB2.2e acids    qh   ah
ZC10.6.4e.  .  iodides   qh

ZC12einorganic nitrogen compounds   qh
ZC12.2e.  inorganic nitrogen acid   qh
BT+ZB2.2e acids    qh   ah
ZC12.2.2e.  .  nitrous acid   qh
ZC12.4e.  ammonia   qh
RT XB2.10.4e urine    qh   ah
ZC12.6e.  cyanide   qh
RT ZJ4.8.2e nitriles    qh   ah
ZC12.6.2e.  .  cyanamide   qh
ZC12.6.2.2e.  .  .  citrated calcium carbimide   qh
ST citrated calcium cyanamide
BT+YD8.2 ADH antagonists    qh   ah
+YP4.8.8e alcohol deterrents    qh   ah
ZC12.6.4.  .  ferricyanide   qh
HN Introduced 1995.
ZC12.6.4.2e.  .  .  sodium nitroprusside   qh
HN Introduced 1995.
ST nitroprusside
BT+YT8.6e vasodilator agents    qh   ah
+YT8.8 antihypertensive agents    qh   ah
ZC12.8e.  nitrogen oxides   qh
BT+ZC16.2e oxides    qh   ah
ZC12.8.2e.  .  nitrates   qh
ZC12.8.2.2e.  .  .  silver nitrate   qh
ZC12.8.4e.  .  nitric oxide   qh
HN Introduced 1995.
BT+YW8e CNS stimulants    qh   ah
ZC12.8.6e.  .  nitrites   qh
ZC12.8.6.2e.  .  .  amyl nitrite   qh
SN A quick-acting volatile inhalant that dilates certain small blood vessels (primarily brain and heart), lowers high blood pressure, and relaxes the smooth (involuntary) muscles of the body. Effects take place within 30 seconds and last only 2 to 3 minutes. Unlike other inhalants, amyl nitrite is a stimulant rather than a depressant and may be dangerous for people with low blood pressure, glaucoma, or anemia. Among illicit users, the drug is prized for its alleged sexual stimulation or prolongation of orgasm effects. It is usually sold in small glass vials.
BT+BGe volatile inhalant    qh   ah
+YT8.6e vasodilator agents    qh   ah
RT ZC12.8.6.4e butyl nitrite    qh   ah
 ZF2.2.10e amyl alcohol    qh   ah
ZC12.8.6.4e.  .  .  butyl nitrite   qh
SN An inhalant drug that first appeared in 1969 after *ZC12.8.6.2 amyl nitrite* qh ah was made a prescription drug. Like amyl nitrite, inhalation of this drug produces a brief but intense lightheaded feeling by lowering blood pressure and relaxing the smooth (involuntary) muscles of the body.
BT+BGe volatile inhalant    qh   ah
+YT8.6e vasodilator agents    qh   ah
ZC12.8.6.6e.  .  .  sodium nitrite   qh
BT+YZ6.8 food preservatives    qh   ah
+ZC4e inorganic sodium compounds    qh   ah
ZC12.8.8e.  .  nitrogen dioxide   qh
ZC12.8.10e.  .  nitrous oxide   qh
SN A short-acting gaseous anesthetic that is sometimes used as an aerosol propellant and is inhaled for its intoxicating effects. A depressant without depressant effects on the spinal cord. When used therapeutically, the effects are those of anesthesia and analgesia. In recreational use, when it is in pure form for less than a minute, its effects are closer to those of the vaporous anesthetics ether and chloroform than other depressants, making the user giddy or exhilarated for about 5 minutes. Occasionally hallucinations occur. Excessive doses may cause nausea, vomiting, or unconsciousness, often because of lack of oxygen. Discovered in the 1770s by Joseph Priestley, but not used as an anesthetic until the middle of the 19th century, it was the first really effective modern anesthetic, followed by ether and chloroform. Also called laughing gas or nitrogen monoxide.
BT+BGe volatile inhalant    qh   ah
+YP4.6e alcohol withdrawal agents    qh   ah
+YR4e anesthetics    qh   ah
+YW4.4e general anesthetics    qh   ah

ZC14einorganic phosphorus compounds   qh
NT EB28.4e phosphorus metabolism    qh   ah
ZC14.2e.  phosphoric acid   qh
BT+ZB2.2e acids    qh   ah
ZC14.2.2e.  .  phosphates   qh
ZC14.2.2.2e.  .  .  polyphosphates   qh
ZC14.2.2.2.2e.  .  .  .  pyrophosphate   qh
BT+EB4.2 high-energy compound    qh   ah
ZC14.4e.  phosphorous acid   qh
BT+ZB2.2e acids    qh   ah

ZC16einorganic oxygen compounds   qh
ZC16.2e.  oxides   qh
NT+ZC12.8e nitrogen oxides    qh   ah
+ZC18.6e sulfur oxide    qh   ah
RT ZB2.8e anhydrides    qh   ah
ZC16.4e.  carbon dioxide   qh
ST CO2
RT ET2.2.6 blood waste transport    qh   ah
 XB2.10.2e exhaled air    qh   ah
ZC16.6e.  carbon monoxide   qh
HN Introduced 1995.
ZC16.8e.  dioxide   qh
ZC16.10e.  peroxide   qh
NT ZC10.2.2e perchloric acid    qh   ah
ZC16.12e.  superoxide   qh

ZC18einorganic sulfur compounds   qh
BT+ZB2.2e acids    qh   ah
ZC18.2e.  inorganic sulfur acid   qh
ZC18.2.2e.  .  sulfenic acid   qh
ZC18.2.4e.  .  sulfuric acid   qh
NT ZC18.8e sulfate    qh   ah
ZC18.4e.  sulfide   qh
ZC18.6e.  sulfur oxide   qh
BT+ZC16.2e oxides    qh   ah
ZC18.6.2e.  .  sulfoxide   qh
ZC18.6.2.2e.  .  .  dimethylsulfoxide   qh
ST DMSO
BT+YL2.4 ethanol antagonists    qh   ah
ZC18.6.4e.  .  sulfur dioxide   qh
ST SO2
ZC18.8e.  sulfate   qh
BT+ZC18.2.4e sulfuric acid    qh   ah
ZC18.10e.  sulfites   qh
RT YC14.34 sulfite oxidase    qh   ah
 YC14.36 sulfite reductase    qh   ah
ZC18.12e.  sulfone   qh
ZC18.14e.  sulfonylurea compounds   qh
ZC18.14.2e.  .  chlorpropamide   qh
BT+YD8.2 ADH antagonists    qh   ah
ZC18.14.4e.  .  tolbutamide   qh
BT+YD8.2 ADH antagonists    qh   ah

ZC20eselenium compounds   qh
NT ZO2.12.2e selenomethionine    qh   ah


ZDeorganic compounds   d-out   qh
NT+YBe vitamins    qh   ah
+YCe enzymes    qh   ah
+YD4e coenzymes    qh   ah
+YD6e cytochromes    qh   ah
+YFe hormones    qh   ah
+YJ2e neurotransmitters    qh   ah
+ZEe hydrocarbons    qh   ah
+ZF alcohols, phenols, and ethers    qh   ah
+ZG aldehydes and ketones    qh   ah
+ZJ carboxylic acids and derivatives    qh   ah
+ZL organic halogen compounds    qh   ah
+ZMe organic nitrogen compounds    qh   ah
+ZR organic phosphorus and sulfur compounds    qh   ah
+ZS nucleic acids, nucleosides, and nucleotides    qh   ah
+ZTe heterocyclic compounds    qh   ah
+ZUe isoprenoids    qh   ah
+ZVe steroids    qh   ah
BT+ZBe chemical compounds    qh   ah


ZEehydrocarbons   d-out   qh
SN A large category of liquid organic chemical compounds that are composed of carbon and hydrogen and are produced only by carbonization from petroleum, coal, and plant life. They evaporate quickly at room temperature (although not as quickly as the vaporous anesthetics) and often are inhaled for their intoxicant effects. Like other inhalants, hydrocarbons are CNS depressants. Commercially, hydrocarbons are used as solvents, aerosols, heating fluid, and gasoline.
NT+ZL2e halogenated hydrocarbons    qh   ah
BT+ZDe organic compounds    qh   ah
RT+BGe volatile inhalant    qh   ah
+BG2 solvent of abuse    qh   ah
+BG6.2 product containing solvent    qh   ah

ZE2eacyclic hydrocarbons   qh
ZE2.2e.  cycloparaffins   qh
ZE2.2.2e.  .  cyclohexanes   qh
ZE2.2.2.2e.  .  .  ketamine   qh
ZE2.2.2.2.2e.  .  .  .  ketamine hydrochloride   qh
ST special K
BT+YW4.4.2 dissociative anesthetics    qh   ah

ZE6ealiphatic hydrocarbons   qh
ZE6.2.  saturated aliphatic hydrocarbons   qh
HN Introduced 1995.
ZE6.4.  unsaturated aliphatic hydrocarbons   qh
HN Introduced 1995.
ZE6.4.6.  .  diene   qh
HN Introduced 1995.
NT ZU2e isoprene    qh   ah
ZE6.4.8.  .  polyene   qh
HN Introduced 1995.
NT ZU12.2e squalene    qh   ah

ZE8earomatic hydrocarbons   qh
ZE8.2e.  benzene   qh
SN A toxic, volatile hydrocarbon derived mainly from the carbonization of coal; prolonged inhalation will result in acute poisoning. It is used extensively in the petroleum, plastic, explosives, and pesticide industries and is most commonly found in gasoline, rubber cement, and paint and varnish removers. Most countries legally regulate the allowable exposure and concentration of fumes in its industrial use as a solvent because of its ability to produce leukemia and severe anemias. It is also called benzol. Methyl benzene is known as toluene.
BT+BG2 solvent of abuse    qh   ah
ZE8.2.2e.  .  benzoid aromatic hydrocarbons   qh
ZE8.2.4e.  .  benzylidene compound   qh
ZE8.2.4.2e.  .  .  styrene   qh
ZE8.2.6e.  .  nitrobenzene   qh
ZE8.4e.  toluene   qh
SN Methyl benzene, the main active ingredient in glue and paint thinner.
BT+BG2 solvent of abuse    qh   ah
RT BB4.6.6.14 paint thinner    qh   ah
ZE8.4.2e.  .  toluene diisocyanate   qh
ZE8.6e.  xylene   qh
ZE8.8.  naphtha   qh
HN Introduced 1995.
SN A highly flammable hydrocarbon obtained by the distillation of petroleum and similar to gasoline and kerosene. It has long been used as a solvent in cleaning fluids and is inhaled for its intoxicating effects.
ST petroleum ether
BT+BG2 solvent of abuse    qh   ah


ZFalcohols, phenols, and ethers   d-out   qh
BT+ZDe organic compounds    qh   ah

ZF2ealcohols (chemical class)   qh
SN Use this descriptor when referring to various chemical forms of alcohol. Use *+BB2 ethanol* qh ah for documents dealing with metabolism, biochemistry, or pharmacology. Use *+BB alcohol in any form* qh ah for materials in which the alcohol form is unspecified or for materials covering all forms of alcohol. Use *+BB4 alcohol product* qh ah and *+BB4.2 alcoholic beverage* qh ah where appropriate.
      In chemical terminology, "alcohols" are a large group of organic compounds derived from hydrocarbons and containing one or more hydroxyl (-OH) groups.
      Alcohol derivatives are classified under the corresponding alcohol.
NT+ZN2.16e amino alcohols    qh   ah
BT+BBe alcohol in any form    qh   ah
RT+BX2e alcohol chemistry    qh   ah
+BX2.2.4e congener    qh   ah
+YC14.2e alcohol oxidoreductases    qh   ah
+YC14.2.2e alcohol dehydrogenases    qh   ah
+YC14.2.2.2e ADH isoenzymes    qh   ah
+ZG2e aldehydes    qh   ah
+ZG2.4e acetaldehyde    qh   ah
ZF2.2e.  primary alcohols   qh
ZF2.2.2e.  .  methanol   qh
ST methyl alcohol
wood alcohol
NT BB2.14 denatured alcohol    qh   ah
RT+ZF2.6e tertiary alcohols    qh   ah
ZF2.2.4e.  .  ethanol and ethanol derivatives   qh
HN Introduced 2000.
NT+BB2e ethanol    qh   ah
ZF2.2.4.2e.  .  .  ifenprodil   qh
HN Introduced 2000.
BT+YT8.6e vasodilator agents    qh   ah
ZF2.2.6e.  .  propyl alcohol   qh
ST 1-propanol
isopropanol
isopropyl alcohol
propanol
propylic alcohol
BT+ZF2.10e fatty alcohols    qh   ah
RT BB4.6.2.2 rubbing alcohol    qh   ah
ZF2.2.8e.  .  butyl alcohol   qh
ST butanol
BT+ZF2.10e fatty alcohols    qh   ah
ZF2.2.8.2e.  .  .  acetoin   qh
ZF2.2.10e.  .  amyl alcohol   qh
ST isopentanol
pentanol
BT+ZF2.10e fatty alcohols    qh   ah
RT ZC12.8.6.2e amyl nitrite    qh   ah
ZF2.2.12e.  .  hexyl alcohol   qh
ST hexanol
BT+ZF2.10e fatty alcohols    qh   ah
ZF2.2.14e.  .  octyl alcohol   qh
ST octanol
ZF2.4e.  secondary alcohols   qh
ZF2.4.2e.  .  glycol   qh
ZF2.4.2.2e.  .  .  butanediol   qh
ZF2.4.2.2.2e.  .  .  .  2,3-butanediol   qh
ZF2.4.2.4.  .  .  chloral hydrate   qh
SN A nonbarbiturate sedative-hypnotic. The hydrate of chloral (trichloroacetaldehyde), which is formed by the chlorination of ethanol. It was the first widely used synthetic sleep-inducing drug. Combined with alcohol, it produces acute intoxication: this combination is known as a Mickey Finn or knockout drop.
ST trichloroacetaldehyde
BT+BT6.8.2 schedule IV CNS depressants    qh   ah
+YP4.6e alcohol withdrawal agents    qh   ah
+YW4.8.4e nonbarbiturate sedative-hypnotics    qh   ah
ZF2.4.2.6e.  .  .  polyethylene glycol   qh
ZF2.4.2.6.2e.  .  .  .  polysorbate   qh
ZF2.4.2.8e.  .  .  propanediol   qh
ZF2.4.2.8.2e.  .  .  .  chloramphenicol   qh
BT+YD8.2 ADH antagonists    qh   ah
+YQ4.14e antibiotics    qh   ah
ZF2.6e.  tertiary alcohols   qh
NT+ZF2.12.2e glycerin    qh   ah
RT+ZF2.2.2e methanol    qh   ah
ZF2.8e.  aliphatic alcohols   qh
ZF2.10e.  fatty alcohols   qh
NT ZF2.2.6e propyl alcohol    qh   ah
+ZF2.2.8e butyl alcohol    qh   ah
 ZF2.2.10e amyl alcohol    qh   ah
 ZF2.2.12e hexyl alcohol    qh   ah
ZF2.10.2e.  .  lauryl alcohol   qh
ZF2.10.2.2.  .  .  sodium dodecyl sulfate   qh
ZF2.10.2.4e.  .  .  sodium tetradecyl sulfate   qh
ZF2.12e.  sugar alcohols   qh
BT+ZG8 carbohydrate-related compounds    qh   ah
RT YC14.2.4.2 sugar alcohol dehydrogenase    qh   ah
ZF2.12.2e.  .  glycerin   qh
ST 1,2,3-propanetriol
glycerol
BT+ZF2.6e tertiary alcohols    qh   ah
RT ZF6.2e glyceryl ether    qh   ah
ZF2.12.2.2e.  .  .  nitroglycerin   qh
ST 1,2,3-propanetriol trinitrate
glyceryl trinitrate
nitroglycerine
BT+YD8.2 ADH antagonists    qh   ah
+YT8.6e vasodilator agents    qh   ah
ZF2.12.4e.  .  inositol   qh
ST cyclohexanohexol
BT+YB12e vitamin B complex    qh   ah
ZF2.12.4.2e.  .  .  inositol phosphate   qh
RT YC4.6.4.6.2 phospholipase C    qh   ah
+YM2.2e second messengers    qh   ah
 ZK2.2.4e phosphoinositide    qh   ah
+ZK2.4.2.2.6e phosphatidylinositol    qh   ah
ZF2.12.4.2.8e.  .  .  .  inositol triphosphate   qh
HN Introduced 2000.
BT+YM2.4e intracellular messengers    qh   ah
ZF2.12.4.2.8.2.  .  .  .  .  inositol 1,3,4 triphosphate   qh
ZF2.12.4.2.8.4.  .  .  .  .  inositol 1,3,4,5-tetrakiphosphate   qh
ZF2.12.4.2.8.6e.  .  .  .  .  inositol 1,4,5-trisphosphate   qh
ST (H super 3) inositol triphosphate
IN(1,4,5)P sub 3
inositol 1,4,5-triphosphate
INs-P3
BT+YM2.2e second messengers    qh   ah
ZF2.12.6e.  .  mannitol   qh
ZF2.12.8e.  .  sorbitol   qh
ZF2.12.8.2e.  .  .  isosorbide   qh
ZF2.12.8.2.2e.  .  .  .  isosorbide dinitrate   qh
BT+YD8.2 ADH antagonists    qh   ah
+YT8.6e vasodilator agents    qh   ah
ZF2.12.10e.  .  xylitol   qh

ZF4ephenols   qh
NT ZF6.8e phenyl ether    qh   ah
+ZJ2.10.10.2.4e hydroxybenzoic acid    qh   ah
 ZM2e nitrophenol    qh   ah
 ZO2.2.4.10e tyrosine    qh   ah
ZF4.2e.  caroverine   qh
BT+YP4.6e alcohol withdrawal agents    qh   ah
+YT8.14e calcium channel blockers    qh   ah
ZF4.4e.  propofol   qh
HN Introduced 2000.
BT+YR4e anesthetics    qh   ah
+YW4.8.4e nonbarbiturate sedative-hypnotics    qh   ah
ZF4.6e.  resveratrol   qh
HN Introduced 2000.
ST RESV
BT+BX2.2.4e congener    qh   ah
+YT8.6e vasodilator agents    qh   ah
ZF4.8e.  polyphenols   qh
HN Introduced 2000.
ZF4.8.2e.  .  tannin   qh
BT+ZG8.2e glycosides    qh   ah
RT BC6.4e tea    qh   ah
+BX2.2.4e congener    qh   ah
ZF4.8.2.2e.  .  .  tannic acid   qh

ZF6eethers   qh
NT+ZK2.4.2.4e phospholipid ether    qh   ah
BT+YW4.4e general anesthetics    qh   ah
RT+BGe volatile inhalant    qh   ah
+YW4.8e sedative-hypnotics    qh   ah
ZF6.2e.  glyceryl ether   qh
RT+ZF2.12.2e glycerin    qh   ah
ZF6.4e.  hydrazine   qh
RT ZJ4.8.4e hydrazides    qh   ah
ZF6.6e.  isoniazid   qh
HN Introduced 1995.
ST isonicotinic acid hydrazide
BT+YQ4.4 antitubercular agents    qh   ah
+ZT4.26.2.8 isonicotinic acid    qh   ah
ZF6.8e.  phenyl ether   qh
BT+ZF4e phenols    qh   ah

ZF8epolycyclic hydrocarbons   qh
ZF8.2.  amantadine   qh
BT+YP10.8.2 anti-cocaine-craving agents    qh   ah
ZF8.4.  maprotiline   qh
BT+YP10.8.10.2 agents for cocaine-concurrent depression    qh   ah
ZF8.6e.  aromatic polycyclic hydrocarbons   qh
HN Introduced 2000.
ZF8.6.2e.  .  naphthalenes   qh
HN Introduced 2000.
ZF8.6.2.2e.  .  .  1-naphthtlamine   qh
HN Introduced 2000.
ZF8.6.2.2.2e.  .  .  .  sertraline   qh
HN Introduced 2000.
BT+YP4.8.2.2e serotonergic anti-alcohol-craving agents    qh   ah
+YV6.6.2e serotonin uptake inhibitors    qh   ah
ZF8.10e.  benzocycloheptene   qh
ZF8.10.2e.  .  dibenzocycloheptene   qh
ZF8.10.2.2e.  .  .  amitriptyline   qh
BT+YP4.8.12.6 agents for alcohol-concurrent depression    qh   ah
ZF8.10.2.4e.  .  .  dizocilpine maleate   qh
HN Introduced 1995.
ST MK-801
BT+YW4.6e anticonvulsants    qh   ah
ZF8.10.2.6e.  .  .  nortriptyline   qh
SN A tricyclic antidepressant, manufactured as Aventyl and Pamelor.
ST nortriptyline hydrochloride
BT+YW6.2 tricyclic antidepressants    qh   ah
ZF8.12e.  indene   qh
ZF8.12.2e.  .  indan   qh
ZF8.12.2.2e.  .  .  ninhydrin   qh
ZF8.14e.  pyrene   qh
BT+YX4e carcinogens    qh   ah


ZGaldehydes and ketones   d-out   qh
SN Aldehydes and ketones are families of similar organic chemical compounds, the molecules of which contain a special grouping of atoms called the carbonyl group. In biological systems, many important compounds, such as the sugars and certain of the steroid hormones, contain aldehyde or ketone groups.
NT+ZHe carbohydrates    qh   ah
BT+ZDe organic compounds    qh   ah

ZG2ealdehydes   qh
NT ZH2.4e aldose    qh   ah
 ZU10.8.6e retinaldehyde    qh   ah
RT+BX2.2.4e congener    qh   ah
 EB10.12.8e ethanol metabolite    qh   ah
+YC10.6 aldehyde lyases    qh   ah
+YC14.4e aldehyde oxidoreductases    qh   ah
+YC14.4.2e aldehyde dehydrogenases    qh   ah
+ZF2e alcohols (chemical class)    qh   ah
ZG2.2e.  formaldehyde   qh
ST methanal
ZG2.2.2e.  .  formocresol   qh
ZG2.4e.  acetaldehyde   qh
SN The principal breakdown product of ethanol. Acetaldehyde is formed by oxidation of ethanol, the reaction being catalyzed principally by alcohol dehydrogenase. Acetaldehyde is oxidized to acetate by aldehyde dehydrogenase. Acetaldehyde is a toxic substance. It is implicated in the alcohol flush reaction and in certain physical sequelae of alcohol consumption.
ST acetic aldehyde
RT+BBe alcohol in any form    qh   ah
+BB2e ethanol    qh   ah
+BX2.2.4e congener    qh   ah
 EB10.12.8e ethanol metabolite    qh   ah
+EX10.2e mutagenesis    qh   ah
 GR2.2e alcohol flush reaction    qh   ah
+ZF2e alcohols (chemical class)    qh   ah
+ZJ2.6.10.4.4.2.2e disulfiram    qh   ah
+ZP24.2e tetrahydroisoquinoline    qh   ah
 ZP24.2.2e salsolinol    qh   ah
+ZT6.12e isoquinolines    qh   ah
ZG2.4.2e.  .  paraldehyde   qh
SN A potent nonbarbiturate sedative/hypnotic. Although considered safe, it has an offensive odor that limits its use.
ST paracetaldehyde
BT+BT6.8.2 schedule IV CNS depressants    qh   ah
+YW4.8.4e nonbarbiturate sedative-hypnotics    qh   ah
RT+YW4.8e sedative-hypnotics    qh   ah
ZG2.6e.  glyceraldehyde   qh
ST 2,3-dihydroxypropanal
glyceric aldehyde
NT ZH2.6e triose    qh   ah
ZG2.6.2e.  .  glyceraldehyde 3-phosphate   qh
ZG2.8e.  glutaraldehyde   qh
ST 1,5-pentanediol
ZG2.10e.  biogenic aldehyde   qh
RT+ZN2.18e biogenic amines    qh   ah
ZG2.12e.  malondialdehyde   qh
ST malonaldehyde
propanedial

ZG4eketones   qh
NT+ZH2.2e ketose    qh   ah
+ZQ10.2e methadone    qh   ah
BT+ZJ2.10.6e keto acids    qh   ah
RT+BX2.2.4e congener    qh   ah
+YC14.12 ketone oxidoreductases    qh   ah
ZG4.2e.  acetone   qh
BT+BG6.2.6 nail polish remover    qh   ah
RT BB2.14 denatured alcohol    qh   ah
+BG2 solvent of abuse    qh   ah
ZG4.4e.  butyrophenones   qh
ZG4.4.2e.  .  haloperidol   qh
SN An (antipsychotic) tranquilizer, manufactured as Haldol..
BT+YP4.6.10 anti-alcohol-related-delirium agents    qh   ah
+YP10.8.6 cocaine blockers    qh   ah
+YW4.10.2.2 butyrophenone tranquilizers    qh   ah

ZG8carbohydrate-related compounds   qh
NT+ZF2.12e sugar alcohols    qh   ah
RT+ZHe carbohydrates    qh   ah
ZG8.2e.  glycosides   qh
NT+YB8e flavonoids    qh   ah
+ZF4.8.2e tannin    qh   ah
+ZS8.2.2e nucleoside diphosphate sugars    qh   ah
RT+YC4.8e glycoside hydrolases    qh   ah
+ZS6e nucleosides    qh   ah
+ZS8e nucleotides    qh   ah
ZG8.2.2e.  .  aminoglycoside   qh
ZG8.2.2.2e.  .  .  gentamicin   qh
BT+YQ4.14.2 aminoglycoside antibiotics    qh   ah
ZG8.2.2.2.2e.  .  .  .  netilmicin   qh
ZG8.2.2.4e.  .  .  neomycin   qh
BT+YQ4.14.2 aminoglycoside antibiotics    qh   ah
ZG8.2.4e.  .  glucoside   qh
RT+ZH2.12.2e glucose    qh   ah
ZG8.2.6e.  .  cardiac glycosides   qh
BT+YT8.10 cardiotonic agents    qh   ah
RT+ZV16e cardanolides    qh   ah
ZG8.2.6.2e.  .  .  strophanthin   qh
BT+ZV16.2e cardenolide    qh   ah
ZG8.2.6.2.2e.  .  .  .  ouabain   qh
ZG8.2.6.4e.  .  .  digitalis glycosides   qh
HN Introduced 2000.
ZG8.2.6.4.2e.  .  .  .  digitonin   qh
HN Introduced 2000.
ZG8.4e.  sugar acids   qh
BT+ZJ2.10.4e hydroxy acids    qh   ah
ZG8.4.2e.  .  neuraminic acid   qh
ZG8.4.2.2e.  .  .  sialic acid   qh
ZG8.4.4e.  .  valproic acid   qh
BT+YP4.6.12 anti-alcohol-related-seizures agents    qh   ah

ZHecarbohydrates   d-out   qh
ST sugars and starches
NT+EB12e carbohydrate metabolism    qh   ah
+GR4e carbohydrate metabolism disorder    qh   ah
 ZO6.4.10.8.4.2.2e carbohydrate-deficient transferrin    qh   ah
BT+ZG aldehydes and ketones    qh   ah
RT+BX2.2.4e congener    qh   ah
+GH14.4e nutritional deficiency    qh   ah
+YAe nutrients    qh   ah
 YC6.2 carbohydrate isomerases    qh   ah
+YC14.2.4e carbohydrate dehydrogenases    qh   ah
+YKe receptors    qh   ah
+ZG8 carbohydrate-related compounds    qh   ah
ZH2e.  monosaccharides   qh
ST simple sugar
ZH2.2e.  .  ketose   qh
BT+ZG4e ketones    qh   ah
ZH2.2.2e.  .  .  xylulose   qh
RT ZH2.10.4e xylose    qh   ah
ZH2.4e.  .  aldose   qh
BT+ZG2e aldehydes    qh   ah
ZH2.6e.  .  triose   qh
BT+ZG2.6e glyceraldehyde    qh   ah
ZH2.8e.  .  tetrose   qh
ZH2.8.2e.  .  .  erythrose   qh
ZH2.8.4e.  .  .  threose   qh
ZH2.10e.  .  pentose   qh
ZH2.10.2e.  .  .  ribose   qh
ZH2.10.4e.  .  .  xylose   qh
RT ZH2.2.2e xylulose    qh   ah
 ZS8.2.2.2e uridine diphosphate sugars    qh   ah
ZH2.12e.  .  hexose   qh
ZH2.12.2e.  .  .  glucose   qh
NT+EB12.2e glucose metabolism    qh   ah
RT GR4.12e hyperglycemia    qh   ah
 GR4.14e hypoglycemia    qh   ah
 HF2e urinalysis    qh   ah
 ZG8.2.4e glucoside    qh   ah
 ZS8.4e uridine diphosphate glucose    qh   ah
ZH2.12.4e.  .  .  fructose   qh
HN Introduced 1995.
ST fruit sugar
levulose
ZH2.12.6e.  .  .  mannose   qh
ZH2.12.8e.  .  .  galactose   qh
RT ZS8.2.2.2e uridine diphosphate sugars    qh   ah
ZH4e.  disaccharides   qh
RT YC4.8.4 disaccharidases    qh   ah
ZH6e.  oligosaccharides   qh
ZH8e.  polysaccharides   qh
RT YC10.16 polysaccharide-lyase    qh   ah
ZH8.2e.  .  glucan   qh
ZH8.2.2e.  .  .  hyaluronic acid   qh
HN Introduced 2000.
SN Body chemical. Levels related to alcohol intake and liver cirrhosis. Possible role in determining blood vessel location in the embryo.
ST hyaluronan
ZH8.2.4e.  .  .  cellulose   qh
BT+YZ8e dietary fiber    qh   ah
+ZY2e natural polymers    qh   ah
ZH8.2.4.2e.  .  .  .  lignin   qh
BT+YZ8e dietary fiber    qh   ah
+ZY2e natural polymers    qh   ah
ZH8.2.4.4e.  .  .  .  glycogen   qh
HN Introduced 1995.
ZH8.2.6e.  .  .  starches   qh
BT+ZY2e natural polymers    qh   ah
RT YC16.6.2.4 glycogen synthase    qh   ah
ZH8.2.6.2e.  .  .  .  amylopectin   qh
ZH8.4e.  .  mucopolysaccharides   qh
ZH8.4.2e.  .  .  sucrose   qh
ZH8.4.2.2e.  .  .  .  sucralfate   qh
BT+YT10.8 antiulcer agents    qh   ah
ZH10e.  pectin   qh
BT+YT10.6 antidiarrheals    qh   ah
+YT14.12 plasma substitutes    qh   ah
+YZ8e dietary fiber    qh   ah
ZH12e.  bacterial polysaccharides   qh
ZH12.2e.  .  lipopolysaccharide   qh
HN Introduced 1995.
BT+YM18e mitogens    qh   ah
ZH14e.  proteoglycan   qh
ZH14.2e.  .  platelet factor 4   qh
BT+ZO6.4.10.6.4e blood coagulation factors    qh   ah


b-out  To Broad Outline    d-out  To Detailed Outline     qh  To Quick Hierarchy
Previous Annotated Hierarchy section    Next Annotated Hierarchy section     Search

classification thesaurus glossary dictionary definition subject heading list ontology vocabulary knowledge structure knowledge organization terminology concept